BlackRock Institutional Trust’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $644K | Hold |
1,074
| – | – | ﹤0.01% | 3396 |
|
|
2016
Q3 | $1.22M | Hold |
1,074
| – | – | ﹤0.01% | 3217 |
|
|
2016
Q2 | $1.18M | Sell |
1,074
-45
| -4% | -$49.3K | ﹤0.01% | 3246 |
|
|
2016
Q1 | $1.44M | Sell |
1,119
-8
| -0.7% | -$10.3K | ﹤0.01% | 3159 |
|
|
2015
Q4 | $2.77M | Buy |
1,127
+145
| +15% | +$356K | ﹤0.01% | 2978 |
|
|
2015
Q3 | $1.08M | Buy |
982
+934
| +1,946% | +$1.03M | ﹤0.01% | 3313 |
|
|
2015
Q2 | $48K | Sell |
48
-428
| -90% | -$428K | ﹤0.01% | 3764 |
|
|
2015
Q1 | $484K | Buy |
476
+2
| +0.4% | +$2.03K | ﹤0.01% | 3503 |
|
|
2014
Q4 | $1.58M | Sell |
474
-11
| -2% | -$36.7K | ﹤0.01% | 3202 |
|
|
2014
Q3 | $1.41M | Buy |
485
+5
| +1% | +$14.5K | ﹤0.01% | 3204 |
|
|
2014
Q2 | $1.83M | Buy |
480
+465
| +3,100% | +$1.77M | ﹤0.01% | 3220 |
|
|
2014
Q1 | $80K | Buy |
15
+12
| +400% | +$64K | ﹤0.01% | 3766 |
|
|
2013
Q4 | $11K | Buy |
+3
| New | +$11K | ﹤0.01% | 3909 |
|